Docetaxel: all 1,319 studies that test it
Page 9 of 14. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.
- Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast CancerCompletedNCT01025349Phase 2
- Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerStatus unknownNCT01019798Phase 2
- Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate CancerCompletedNCT01012141Phase 2
- A Study of YM155 Plus Docetaxel in Subjects With Stage III (Unresectable) or Stage IV MelanomaCompletedNCT01009775Phase 2
- Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung CancerCompletedNCT01004601Not applicable
- Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCompletedNCT00995293Phase 3
- Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast CancerStatus unknownNCT00994968Phase 2
- Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerTerminatedNCT00983047Phase 2
- Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric CancerStatus unknownNCT00980603Phase 2
- A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric CarcinomaCompletedNCT00980382Phase 1/2
- Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast CancerTerminatedNCT00979641Phase 2
- Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerCompletedNCT00978549Phase 3
- Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXPCompletedNCT00976976Phase 2
- A Study of MGCD265 Given With Erlotinib or Docetaxel in Subjects With Advanced Malignancies or Non-Small Cell Lung CancerTerminatedNCT00975767Phase 1
- Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic CancerCompletedNCT00966706Phase 2
- A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast CancerWithdrawnNCT00964704Phase 2
- Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By SurgeryCompletedNCT00963729Phase 3
- A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer EarlyStatus unknownNCT00957125Phase 2
- Carboplatin and Docetaxel Followed by Epstein-Barr Virus Cytotoxic T LymphocytesCompletedNCT00953420Phase 2
- Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer PatientsCompletedNCT00952003Phase 2
- Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow MicrometastasesCompletedNCT00949247Early Phase 1
- Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast caStatus unknownNCT00944424Phase 3
- S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
- RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerCompletedNCT00935961Phase 1
- Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.CompletedNCT00933517Phase 2
- Study to Evaluate SID 530 Compared to TaxotereCompletedNCT00931008Phase 3
- Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate CancerCompletedNCT00916123Phase 1
- NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)CompletedNCT00916097Phase 2
- Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast CancerTerminatedNCT00912444Phase 3
- TC Avastin. ICORG 08-10, V6CompletedNCT00911716Not applicable
- Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy RegimenStatus unknownNCT00908336Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00906061Phase 2
- Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) PatientsStatus unknownNCT00905983Phase 2
- Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With CancerCompletedNCT00888108Phase 1
- Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced AdenocarcinomaCompletedNCT00883480Not applicable
- Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid TumorsCompletedNCT00881166Phase 1
- Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast CancerCompletedNCT00872625Phase 1
- Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot StudyStatus unknownNCT00870714Not applicable
- Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck CancerCompletedNCT00868491Phase 2
- Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal CancerStatus unknownNCT00865982Phase 2
- Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionCompletedNCT00849615Phase 2
- A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast CancerTerminatedNCT00845910Phase 2
- Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric CancerStatus unknownNCT00845884Phase 1/2
- Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line TreatmentCompletedNCT00840125Phase 2
- Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-TaxCompletedNCT00826852Phase 2
- TaxXel: Taxotere and Xeloda in Esophageal CancerStatus unknownNCT00821912Phase 1/2
- Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerCompletedNCT00819728Phase 2
- Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC)Status unknownNCT00817583Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal CarcinomaStatus unknownNCT00816855Phase 2
- Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal CarcinomaStatus unknownNCT00816816Phase 2
- Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal AdenocarcinomaCompletedNCT00816543Phase 2
- Second-line Therapy Study of Combined Chemotherapy and Endostar to Patients With Non-Small Cell Lung Cancer(NSCLC)Status unknownNCT00813332Phase 4
- A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
- Taxotere New Indication - Gastric Cancer Treatment Registration TrialCompletedNCT00811447Phase 3
- Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)WithdrawnNCT00811031Phase 2
- A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate CancerCompletedNCT00808418Phase 1
- Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination ChemotherapyStatus unknownNCT00807261Phase 2
- Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00805012Phase 2
- Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by SurgeryStatus unknownNCT00801411Phase 2
- Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate CancerStatus unknownNCT00796458Phase 3
- Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00783471Phase 2
- PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast CancerWithdrawnNCT00774241Phase 4
- A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerCompletedNCT00773695Phase 2
- Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian CancerCompletedNCT00772863Phase 2
- Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx CarcinomaCompletedNCT00772681Phase 4
- Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES)CompletedNCT00771563Phase 3
- Phase II Avastin Trial for Stage IIIB/IV NSCLCTerminatedNCT00766246Phase 2
- Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung CancerWithdrawnNCT00755157Phase 2
- Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast CancerCompletedNCT00754351Phase 2
- Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung CancerCompletedNCT00741195Phase 2
- Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus CancerCompletedNCT00737373Phase 2
- First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryStatus unknownNCT00736814Phase 2
- Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General StatusCompletedNCT00733616Phase 2
- Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate CancerCompletedNCT00728663Phase 2
- Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate CancerCompletedNCT00723086Phase 2
- Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric CancerCompletedNCT00718913Phase 2
- A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast CancerStatus unknownNCT00717951Phase 2
- Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer PatientsTerminatedNCT00714376Phase 2
- Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00714246Phase 1
- Study Of SU011248 In Combination With Docetaxel In Patients With Advanced CancerCompletedNCT00712504Phase 1
- Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate CancerTerminatedNCT00705822Phase 3
- Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung CancerTerminatedNCT00705549Phase 2
- Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast CancerCompletedNCT00705315Phase 1/2
- Phase I Study of Docetaxel and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703625Phase 1
- Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic CycleCompletedNCT00703378Phase 1/2
- A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung CancerWithdrawnNCT00697060Phase 2
- The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian PatientsCompletedNCT00695994Phase 2
- Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic CancerStatus unknownNCT00690300Phase 2
- Epirubicin or Not in Patients With TOP2A (Topoisomerase (DNA) II Alpha (170kD)) Normal Early Breast CancerCompletedNCT00689156Phase 3
- Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung CancerCompletedNCT00686985Phase 2
- Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00684099Phase 1/2
- Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC)CompletedNCT00682383Phase 2
- A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) PatientsCompletedNCT00675545Phase 2
- The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus AdenocarcinomaStatus unknownNCT00674167Phase 2
- Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer PatientStatus unknownNCT00669773Phase 2
- Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT00669370Phase 2
- Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical RadiotherapyStatus unknownNCT00653848Phase 3
- Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerTerminatedNCT00651326Phase 3
- Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast CancerCompletedNCT00645866Phase 2
- Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00630110Phase 1/2